SG3 Management’s STAAR Surgical STAA Stock Holding History

SG3 Management’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-10,000	Closed	-$615K	–	1058
2020 Q2	$615K	Buy	+10,000	New	+$408K	0.04%	360

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EFM

E Fund Management Guangzhou, China $3.37B AUM

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

SG3 Management's STAA Position: Q3 2020 in Review

SG3 Management sold out of STAAR Surgical (STAA) in Q3 2020, closing a stake of 20,000 shares — an estimated $1.23M sold.

SG3 Management first reported a position in STAA in Q4 2019 and held it in 2 quarters. The position peaked at $1.23M in Q2 2020. 177 funds tracked by Wall St. Rank hold STAA as of Q3 2020.

SG3 Management reported no remaining STAAR Surgical position as of Q3 2020 after selling out during the quarter.
SG3 Management sold 20,000 STAAR Surgical shares in Q3 2020, an estimated $1.23M.
SG3 Management first reported a position in STAAR Surgical in Q4 2019 and held it in 2 quarters.
SG3 Management's STAAR Surgical position peaked at $1.23M in Q2 2020.
177 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2020.

Based on SG3 Management's 13F filing for Q3 2020, filed 13 Nov 2020.